47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
22.22.Z - Manufacture of plastic packaging
23.13.Z - Production of household glass
26.30.Z - Manufacture of (tele)communication equipment
26.51.Z - Manufacture of measuring, controlling, and navigation instruments
26.60.Z - Manufacture of irradiation equipment, electromedical and electrotherapeutic equipment
26.70.Z - Manufacture of optical instruments, magnetic and optical information carriers, and photographic equipment
28.29.Z - Manufacture of other general-purpose machinery not elsewhere classified
28.99.Z - Manufacture of other special-purpose machinery not elsewhere classified
31.01.Z - Manufacture of furniture
32.50.Z - Production of medical devices, instruments, and products, including dental products
32.99.Z - Production of other products not classified elsewhere
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
82.99.Z - Other business support activities, not elsewhere classified
85.60.Z - Educational support activities
86.90.E - Healthcare
87.20.Z - Social assistance with accommodation for people with mental disorders or addictions
88.99.Z - Other social assistance without accommodation, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1 | 0,7 | 0,5 | -34,3 |
EBITDA | 1 | 0,8 | 0,5 | -32,1 |
Short time liabilities | 0,9 | 0,9 | 0,9 | -0,8 |
Equity capital | 2 | 2 | 2 | -3,5 |
Operating profit (EBIT) | 1 | 0,7 | 0,5 | -34,9 |
Assets | 3 | 3 | 2,9 | -3,8 |
Net profit (loss) | 1 | 0,7 | 0,5 | -34,3 |
Cash | 0,5 | 0,4 | 0,3 | -26,6 |
Net income from sale | 5,6 | 5,4 | 5,3 | -3,2 |
Liabilities and provisions for liabilities | 1,1 | 1 | 0,9 | -4,3 |
Working assets | 2,8 | 2,8 | 2,6 | -5 |
Depreciation | 0 | 0,1 | 0,1 | 2,9 |
% | % | % | p.p. | |
Profitability of capital | 51,2 | 35,4 | 24,1 | -11,3 |
Equity capital to total assets | 64,8 | 67,4 | 67,5 | 0,1 |
Gross profit margin | 17,8 | 13,2 | 9 | -4,2 |
EBITDA Margin | 18,4 | 14,4 | 10,1 | -4,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 61 | 61 | 62 | 1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane